ELECTRA PRESCRIBING SERVICES LTD

Company Registration Number:
12111397 (England and Wales)

Unaudited abridged accounts for the year ended 31 July 2025

Period of accounts

Start date: 01 August 2024

End date: 31 July 2025

ELECTRA PRESCRIBING SERVICES LTD

Contents of the Financial Statements

for the Period Ended 31 July 2025

Balance sheet
Notes

ELECTRA PRESCRIBING SERVICES LTD

Balance sheet

As at 31 July 2025


Notes
2025
2024


£
£
Fixed assets
Intangible assets: 3 700,000 700,000
Tangible assets: 4 293,103 317,664
Total fixed assets: 993,103 1,017,664
Current assets
Stocks: 105,072 50,928
Debtors:   22,982 174,772
Cash at bank and in hand: 541,678 229,074
Total current assets: 669,732 454,774
Creditors: amounts falling due within one year:   (436,794) (259,910)
Net current assets (liabilities): 232,938 194,864
Total assets less current liabilities: 1,226,041 1,212,528
Creditors: amounts falling due after more than one year:   (143,728) (333,328)
Total net assets (liabilities): 1,082,313 879,200
Capital and reserves
Called up share capital: 236 236
Profit and loss account: 1,082,077 878,964
Shareholders funds: 1,082,313 879,200

The notes form part of these financial statements

ELECTRA PRESCRIBING SERVICES LTD

Balance sheet statements

For the year ending 31 July 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 31 March 2026
and signed on behalf of the board by:

Name: Arif Elyas Vardalia
Status: Director

The notes form part of these financial statements

ELECTRA PRESCRIBING SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ELECTRA PRESCRIBING SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

2. Employees

2025 2024
Average number of employees during the period 8 8

ELECTRA PRESCRIBING SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

3. Intangible Assets

Total
Cost £
At 01 August 2024 700,000
At 31 July 2025 700,000
Net book value
At 31 July 2025 700,000
At 31 July 2024 700,000

ELECTRA PRESCRIBING SERVICES LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

4. Tangible Assets

Total
Cost £
At 01 August 2024 404,335
Additions 12,820
At 31 July 2025 417,155
Depreciation
At 01 August 2024 86,671
Charge for year 37,381
At 31 July 2025 124,052
Net book value
At 31 July 2025 293,103
At 31 July 2024 317,664